We are live on ! Find out more
YIH

Y-Intercept (HK) Portfolio holdings

AUM $5.05B
1-Year Est. Return 17.89%
This Fund
S&P 500
This Quarter Est. Return
-0.78%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
AUM
$550M
AUM Growth
+$157M
Cap. Flow
+$181M
Cap. Flow %
32.82%
Top 10 Hldgs %
9.69%
Holding
1,013
New
425
Increased
119
Reduced
70
Closed
399

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$5.22M
2
A icon
Agilent Technologies
A
+$4.93M
3
MSFT icon
Microsoft
MSFT
+$4.87M
4
TRI icon
Thomson Reuters
TRI
+$4.55M
5
NEE icon
NextEra Energy
NEE
+$4.49M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$12.2M
2
MRNA icon
Moderna
MRNA
+$8.97M
3
AAPL icon
Apple
AAPL
+$5.54M
4
QCOM icon
Qualcomm
QCOM
+$4.48M
5
UNH icon
UnitedHealth
UNH
+$4.44M

Sector Composition

Rank Sector Weight
1 Technology 17%
2 Healthcare 13.82%
3 Consumer Discretionary 11.58%
4 Financials 11.56%
5 Industrials 10.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPTU
26
Optimum Communications Inc
OPTU
$316M
$2.65M 0.48%
127,913
+111,777
+693% +$3.26M
VALE icon
27
Vale
VALE
$62.9B
$2.61M 0.47%
+187,129
New +$3.67M
EW icon
28
Edwards Lifesciences
EW
$47.6B
$2.58M 0.47%
+22,795
New +$2.6M
ETN icon
29
Eaton
ETN
$157B
$2.57M 0.47%
+17,206
New +$2.75M
DOV icon
30
Dover
DOV
$27.2B
$2.54M 0.46%
+16,349
New +$2.71M
GRMN
31
Garmin
GRMN
$46.9B
$2.54M 0.46%
+16,336
New +$2.66M
EPAM icon
32
EPAM Systems
EPAM
$4.69B
$2.51M 0.46%
+4,394
New +$2.59M
REGN icon
33
Regeneron Pharmaceuticals
REGN
$68.8B
$2.5M 0.45%
4,133
-73
-2% -$45.3K
FNV icon
34
Franco-Nevada
FNV
$41.4B
$2.47M 0.45%
+19,046
New +$2.79M
PG icon
35
Procter & Gamble
PG
$343B
$2.45M 0.45%
17,534
+12,794
+270% +$1.81M
SBAC icon
36
SBA Communications
SBAC
$18.4B
$2.43M 0.44%
+7,349
New +$2.54M
TROW icon
37
T. Rowe Price
TROW
$25B
$2.43M 0.44%
+12,340
New +$2.6M
PPG icon
38
PPG Industries
PPG
$25.9B
$2.42M 0.44%
16,906
+9,596
+131% +$1.54M
TT icon
39
Trane Technologies
TT
$106B
$2.41M 0.44%
+13,946
New +$2.68M
WDAY icon
40
Workday
WDAY
$33.4B
$2.41M 0.44%
+9,633
New +$2.39M
YUM icon
41
Yum! Brands
YUM
$41B
$2.39M 0.43%
19,552
+14,115
+260% +$1.79M
ILMN icon
42
Illumina
ILMN
$29.4B
$2.38M 0.43%
+6,046
New +$2.78M
NVO
43
Novo Nordisk
NVO
$216B
$2.38M 0.43%
+49,664
New +$2.4M
AWK icon
44
American Water Works
AWK
$26.3B
$2.38M 0.43%
14,064
+10,560
+301% +$1.85M
PLD icon
45
Prologis
PLD
$138B
$2.36M 0.43%
18,780
+11,019
+142% +$1.43M
WAT icon
46
Waters Corp
WAT
$36.8B
$2.35M 0.43%
+6,577
New +$2.58M
DHR icon
47
Danaher
DHR
$135B
$2.31M 0.42%
+8,578
New +$2.34M
JNJ icon
48
Johnson & Johnson
JNJ
$635B
$2.26M 0.41%
14,012
+6,389
+84% +$1.09M
GOOGL icon
49
Alphabet (Google) Class A
GOOGL
$3.91T
$2.26M 0.41%
+16,920
New +$2.3M
CCI icon
50
Crown Castle
CCI
$32.7B
$2.25M 0.41%
+12,977
New +$2.51M

Similar funds

Y-Intercept (HK)'s Q3 2021 Portfolio in Review

As of Q3 2021, Y-Intercept (HK) held 1,013 positions worth $550M, up 40% from $393M the previous quarter. Its ten largest holdings account for 9.7% of the portfolio.

Y-Intercept (HK) deployed $181M of net new capital in Q3 2021, opening 425 new positions and adding to 119 existing holdings. Its largest new stake was Nike: 32,025 shares worth $4.65M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $5.54M trimmed.

  • Y-Intercept (HK)'s largest Q3 2021 buy was Nike: 32,025 shares worth $4.65M.
  • Y-Intercept (HK) added most to Microsoft in Q3 2021, an estimated $4.87M increase.
  • Y-Intercept (HK)'s biggest Q3 2021 reduction was Apple, cutting an estimated $5.54M.
  • Y-Intercept (HK) fully exited Linde in Q3 2021, selling an estimated $12.2M.
  • Y-Intercept (HK)'s ten largest holdings make up 9.7% of its $550M portfolio in Q3 2021.
  • Y-Intercept (HK) opened 425 new positions and closed 399 in Q3 2021.
  • Y-Intercept (HK)'s portfolio value rose 40% quarter-over-quarter to $550M.

Based on Y-Intercept (HK)'s 13F filing for Q3 2021, filed 15 Nov 2021.